<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">oncotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский онкологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian journal of oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-4861</issn><issn pub-type="epub">2312-3168</issn><publisher><publisher-name>Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21294/1814-4861-2020-19-3-102-108</article-id><article-id custom-type="elpub" pub-id-type="custom">oncotomsk-1493</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛАБОРАТОРНЫЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LABORATORY AND EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>РОЛЬ N-АЦЕТИЛЦИСТЕИНА В РЕГУЛЯЦИИ АПОПТОЗА ОПУХОЛЕВЫХ КЛЕТОК ЛИНИИ Р19 ПРИ ГИПОКСИИ</article-title><trans-title-group xml:lang="en"><trans-title>EFFECT OF N-ACETYLCYSTEINE ON APOPTOSIS OF P19 CANCER CELLS DURING HYPOXIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7441-5554</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Носарева</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Nosareva</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, доцент, профессор кафедры биохимии и молекулярной биологии с курсом клинической лабораторной диагностики,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>MD, DSc, Professor of the Division of Biochemistry and Molecular Biology with Clinical Laboratory Diagnostics, </p><p>2, Moskovsky Trakt Street, 634050-Tomsk</p></bio><email xlink:type="simple">olnosareva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7525-0176</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлов</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlov</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры биохимии и молекулярной биологии с курсом клинической лабораторной диагностики,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>Assistant of the Division of Biochemistry and Molecular Biology with Clinical Laboratory Diagnostics,</p><p>2, Moskovsky Trakt Street, 634050-Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2938-1137</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шахристова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shakhristova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры биохимии и молекулярной биологии с курсом клинической лабораторной диагностики,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>MD, PhD, Associate Professor of the Division of Biochemistry and Molecular Biology with Clinical Laboratory Diagnostics,</p><p>2, Moskovsky Trakt Street, 634050-Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9339-6304</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Степовая</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Stepovaya</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры биохимии и молекулярной биологии с курсом клинической лабораторной диагностики,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>MD, DSc, Professor, Division of Biochemistry and Molecular Biology with Clinical Laboratory Diagnostics,</p><p>2, Moskovsky Trakt Street, 634050-Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4093-4927</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Садыкова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sadykova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры биохимии и молекулярной биологии с курсом клинической лабораторной диагностики,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>MD, PhD, Associate Professor of the Division of Biochemistry and Molecular Biology with Clinical Laboratory Diagnostics,</p><p>2, Moskovsky Trakt Street, 634050-Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Сибирский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>04</day><month>07</month><year>2020</year></pub-date><volume>19</volume><issue>3</issue><fpage>102</fpage><lpage>108</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Носарева О.Л., Орлов Д.С., Шахристова Е.В., Степовая Е.А., Садыкова А.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Носарева О.Л., Орлов Д.С., Шахристова Е.В., Степовая Е.А., Садыкова А.А.</copyright-holder><copyright-holder xml:lang="en">Nosareva O.L., Orlov D.S., Shakhristova E.V., Stepovaya E.A., Sadykova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.siboncoj.ru/jour/article/view/1493">https://www.siboncoj.ru/jour/article/view/1493</self-uri><abstract><sec><title>Введение</title><p>Введение. Гипоксия при опухолевом росте способствует формированию дисфункции митохондрий и выступает дополнительным фактором, усугубляющим окислительный стресс в иммортализированной клетке. Цель исследования – изучение молекулярных механизмов воздействия N-ацетилцистеина на редокс-регуляцию апоптоза опухолевых клеток при гипоксии.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Материалом для исследования служили культивированные в условиях гипоксии опухолевые клетки линии Р19 (тератокарцинома мыши). Редокс-статус модулировали N-ацетилцистеином (конечная концентрация 5 мМ). Методом проточной цитофлуориметрии определяли содержание активных форм кислорода, концентрацию ионов кальция, трансмембранный потенциал митохондрий, количество CD95-, CD120- и аннексин V-положительных клеток. Концентрацию компонентов системы глутатиона, SH-групп протеинов и карбонильных производных белков измеряли методом спектрофотометрии.</p></sec><sec><title>Результаты</title><p>Результаты. Применение N-ацетилцистеина в условиях гипоксии сопровождалось значимым увеличением концентрации общего глутатиона и SH-групп белков, снижением содержания ионов Са2+, белковосвязанного глутатиона и карбонильных производных протеинов, а также продукции активных форм кислорода и более адекватным функционированием митохондрий клеток линии Р19. N-ацетилцистеин способствовал формированию дополнительной устойчивости опухолевых клеток линии Р19 к апоптозу в условиях гипоксии.</p></sec><sec><title>Заключение</title><p>Заключение. В условиях гипоксии изменение состояния системы глутатиона влияет на изменение метаболизма опухолевой клетки в целом и способствует формированию дополнительных механизмов ускользания от клеточной гибели. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Hypoxia in tumor growth contributes to mitochondrial dysfunction and exacerbates oxidative stress in the immortalized cell. The objective of the study was to investigate the molecular mechanisms of the effects of N-acetylcysteine on redox regulation of tumor cell apoptosis under hypoxia.</p></sec><sec><title>Material and Methods</title><p>Material and Methods. P19 cells (mouse teratocarcinoma) cultured under hypoxia served as the material for the study. The redox status was modulated with N-acetylcysteine in the final concentration of 5 mM. The level of reactive oxygen species, concentration of calcium ions, transmembrane potential and the number of CD95-, CD120- and Annexin V-positive cells were determined by flow cytometry. The concentration of glutathione system components as well as the levels of protein SH groups and protein carbonyl derivatives were measured by spectrophotometry.</p></sec><sec><title>Results</title><p>Results. The use of N-acetylcysteine under hypoxic conditions was accompanied by the increased total glutathione concentration and protein SH groups levels, decreased levels of Са2+ ions, proteinbound glutathione and protein carbonyl derivatives, as well as the production of reactive oxygen species and more appropriate functioning of P19 cells mitochondria. N-acetylcysteine contributed to the development of additional resistance of P19 cells to apoptosis under hypoxia.</p></sec><sec><title>Conclusion</title><p>Conclusion. The alteration in the state of the glutathione system under hypoxia influences the changes in tumor cell metabolism on the whole and promotes formation of additional mechanisms to escape apoptosis. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>опухолевый рост</kwd><kwd>апоптоз</kwd><kwd>окислительный стресс</kwd><kwd>гипоксия</kwd><kwd>система глутатиона</kwd><kwd>N-ацетилцистеин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tumor growth</kwd><kwd>apoptosis</kwd><kwd>oxidative stress</kwd><kwd>hypoxia</kwd><kwd>glutathione system</kwd><kwd>N-acetylcystein</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sinha K., Das J., Pal P.B., Sil P.C. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol. 2013 Jul; 87(7): 1157–80. doi: 10.1007/s00204-013-1034-4.</mixed-citation><mixed-citation xml:lang="en">Sinha K., Das J., Pal P.B., Sil P.C. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol. 2013 Jul; 87(7): 1157–80. doi: 10.1007/s00204-013-1034-4.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y., Zhang H., Zhou H.J., Ji W., Min W. Mitochondrial Redox Signaling and Tumor Progression. Cancers (Basel). 2016 Mar 25; 8(4). pii: E40. doi: 10.3390/cancers8040040.</mixed-citation><mixed-citation xml:lang="en">Chen Y., Zhang H., Zhou H.J., Ji W., Min W. Mitochondrial Redox Signaling and Tumor Progression. Cancers (Basel). 2016 Mar 25; 8(4). pii: E40. doi: 10.3390/cancers8040040.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Redza-Dutordoir M., Averill-Bates D.A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016 Dec; 1863(12): 2977–2992. doi: 10.1016/j.bbamcr.2016.09.012.</mixed-citation><mixed-citation xml:lang="en">Redza-Dutordoir M., Averill-Bates D.A. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016 Dec; 1863(12): 2977–2992. doi: 10.1016/j.bbamcr.2016.09.012.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mailloux R.J., Jin X., Willmore W.G. Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol. 2013 Dec 19; 2: 123–39. doi: 10.1016/j.redox.2013.12.011.</mixed-citation><mixed-citation xml:lang="en">Mailloux R.J., Jin X., Willmore W.G. Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol. 2013 Dec 19; 2: 123–39. doi: 10.1016/j.redox.2013.12.011.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Степовая Е.А., Рязанцева Н.В., Носарева О.Л., Закирова Е.В., Наумова А.И., Веснина О.Н., Орлов Д.С., Шахристова Е.В., Иванов В.В., Новицкий В.В. Роль окислительной модификации белков в редокс-зависимой регуляции апоптоза опухолевых клеток. Молекулярная медицина. 2015; 4: 60–64.</mixed-citation><mixed-citation xml:lang="en">Stepovaya E.A., Ryazantseva N.V., Nosareva O.L., Zakirova E.V., Naumova A.I., Vesnina O.N., Orlov D.S., Shakhristova E.V., Ivanov V.V., Novitsky V.V. The role of oxidative protein modification in redox-dependent regulation of tumor cell apoptosis. Molecular medicine. 2015; 4: 60–64. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shakhristova E.V., Stepovaya E.A., Ryazantseva N.V., Nosareva O.L., Yakushina V.D., Ivanov V.V., Novitskii V.V. Role of Glutathione System Redox Potential in Apoptosis Dysregulation in MCF-7 Breast Adenocarcinoma. Bull Exp Biol Med. 2016 Jan; 160(3): 364–7. doi: 10.1007/s10517-016-3172-1.</mixed-citation><mixed-citation xml:lang="en">Shakhristova E.V., Stepovaya E.A., Ryazantseva N.V., Nosareva O.L., Yakushina V.D., Ivanov V.V., Novitskii V.V. Role of Glutathione System Redox Potential in Apoptosis Dysregulation in MCF-7 Breast Adenocarcinoma. Bull Exp Biol Med. 2016 Jan; 160(3): 364–7. doi: 10.1007/s10517-016-3172-1.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Moldogazieva N.T., Mokhosoev I.M., Feldman N.B., Lutsenko S.V. ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications. Free Radic Res. 2018 May; 52(5): 507–543. doi: 10.1080/10715762.2018.1457217.</mixed-citation><mixed-citation xml:lang="en">Moldogazieva N.T., Mokhosoev I.M., Feldman N.B., Lutsenko S.V. ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications. Free Radic Res. 2018 May; 52(5): 507–543. doi: 10.1080/10715762.2018.1457217.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marengo B., Nitti M., Furfaro A.L., Colla R., Ciucis C.D., Marinari U.M., Pronzato M.A., Traverso N., Domenicotti C. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy. Oxid Med Cell Longev. 2016; 2016: 6235641. doi: 10.1155/2016/6235641.</mixed-citation><mixed-citation xml:lang="en">Marengo B., Nitti M., Furfaro A.L., Colla R., Ciucis C.D., Marinari U.M., Pronzato M.A., Traverso N., Domenicotti C. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy. Oxid Med Cell Longev. 2016; 2016: 6235641. doi: 10.1155/2016/6235641.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mailloux R.J., Treberg J.R. Protein S-glutathionlyation links energy metabolism to redox signaling in mitochondria. Redox Biol. 2016 Aug; 8: 110–8. doi: 10.1016/j.redox.2015.12.010.</mixed-citation><mixed-citation xml:lang="en">Mailloux R.J., Treberg J.R. Protein S-glutathionlyation links energy metabolism to redox signaling in mitochondria. Redox Biol. 2016 Aug; 8: 110–8. doi: 10.1016/j.redox.2015.12.010.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dominko K., Đikić D. Glutathionylation: a regulatory role of glutathione in physiological processes. Arh Hig Rada Toksikol. 2018; 69(1): 1–24. doi: 10.2478/aiht-2018-69-2966.</mixed-citation><mixed-citation xml:lang="en">Dominko K., Đikić D. Glutathionylation: a regulatory role of glutathione in physiological processes. Arh Hig Rada Toksikol. 2018; 69(1): 1–24. doi: 10.2478/aiht-2018-69-2966.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bak D.W., Weerapana E. Cysteine-mediated redox signalling in the mitochondria. Mol Biosyst. 2015; 11(3): 678–97. doi: 10.1039/c4mb00571f.</mixed-citation><mixed-citation xml:lang="en">Bak D.W., Weerapana E. Cysteine-mediated redox signalling in the mitochondria. Mol Biosyst. 2015; 11(3): 678–97. doi: 10.1039/c4mb00571f.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Степовая Е.А., Шахристова Е.В., Рязанцева Н.В., Носарева О.Л., Чильчигашев Р.И., Егорова М.Ю. Система тиоредоксина в регуляции пролиферации клеток линии MCF-7 при модуляции редоксстатуса. Сибирский онкологический журнал. 2016; 15(4): 50–55. doi: 10.21294/1814-4861-2016-15-4-50-55.</mixed-citation><mixed-citation xml:lang="en">Stepovaya E.A., Shakhristova E.V., Ryazantseva N.V., Nosareva O.L., Chil’chigashev R.I., Egorova M.Y. The thioredoxin system in regulating MCF-7 cell proliferation under redox status modulation. Siberian Journal of Oncology. 2016; 15(4): 50–55. (in Russian). doi: 10.21294/1814-4861-2016-15-4-50-55.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nosareva O.L., Stepovaya E.A., Ryazantseva N.V., Shakhristova E.V., Egorova M.Y., Novitsky V.V. The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells. Bull Exp Biol Med. 2017; 164(2): 199–202. doi: 10.1007/s10517-017-3957-x.</mixed-citation><mixed-citation xml:lang="en">Nosareva O.L., Stepovaya E.A., Ryazantseva N.V., Shakhristova E.V., Egorova M.Y., Novitsky V.V. The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells. Bull Exp Biol Med. 2017; 164(2): 199–202. doi: 10.1007/s10517-017-3957-x.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Šalamon Š., Kramar B., Marolt T.P., Poljšak B., Milisav I. Medical and Dietary Uses of N-Acetylcysteine. Antioxidants (Basel). 2019 Apr 28; 8(5): 111. doi: 10.3390/antiox8050111.</mixed-citation><mixed-citation xml:lang="en">Šalamon Š., Kramar B., Marolt T.P., Poljšak B., Milisav I. Medical and Dietary Uses of N-Acetylcysteine. Antioxidants (Basel). 2019 Apr 28; 8(5): 111. doi: 10.3390/antiox8050111.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kojima S., Nakayama K., Ishida H. Low dose gamma-rays activate immune functions via induction of glutathione and delay tumor growth. J Radiat Res. 2004 Mar; 45(1): 33–9. doi: 10.1269/jrr.45.33.</mixed-citation><mixed-citation xml:lang="en">Kojima S., Nakayama K., Ishida H. Low dose gamma-rays activate immune functions via induction of glutathione and delay tumor growth. J Radiat Res. 2004 Mar; 45(1): 33–9. doi: 10.1269/jrr.45.33.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Burchill B.R., Oliver J.M., Pearson C.B., Leinbach E.D., Berlin R.D. Microtubule dynamics and glutathione metabolism in phagocytizing human polymorphonuclear leukocytes. J Cell Biol. 1978; 76(2): 439–47. doi: 10.1083/jcb.76.2.439.</mixed-citation><mixed-citation xml:lang="en">Burchill B.R., Oliver J.M., Pearson C.B., Leinbach E.D., Berlin R.D. Microtubule dynamics and glutathione metabolism in phagocytizing human polymorphonuclear leukocytes. J Cell Biol. 1978; 76(2): 439–47. doi: 10.1083/jcb.76.2.439.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнян А.В., Дубинина Е.Е., Зыбина Н.Н. Методы оценки свободнорадикального окисления и антиоксидантной защиты организма. СПб.; 2000. 103 с.</mixed-citation><mixed-citation xml:lang="en">Arutyunyan A.V., Dubinina E.E., Zybina N.N. Methods of assessing free radical oxidation and antioxidant defense of the body. Saint-Peterburg; 2000. 103 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976 May 7; 72: 248–54. doi: 10.1006/abio.1976.9999.</mixed-citation><mixed-citation xml:lang="en">Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976 May 7; 72: 248–54. doi: 10.1006/abio.1976.9999.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Merritt J.E., McCarthy S.A., Davies M.P., Moores K.E. Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca2+. Biochem. J. 1990; 269(2): 513–9. doi: 10.1042/bj2690513.</mixed-citation><mixed-citation xml:lang="en">Merritt J.E., McCarthy S.A., Davies M.P., Moores K.E. Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca2+. Biochem. J. 1990; 269(2): 513–9. doi: 10.1042/bj2690513.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gomes A., Fernandes E., Lima J.L. Fluo rescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods. 2005 Dec 31; 65(2–3): 45–80. doi: 10.1016/j.jbbm.2005.10.003.</mixed-citation><mixed-citation xml:lang="en">Gomes A., Fernandes E., Lima J.L. Fluo rescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods. 2005 Dec 31; 65(2–3): 45–80. doi: 10.1016/j.jbbm.2005.10.003.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Briehl M.M., Tome M.E., Wilkinson S.T., Jaramillo M.C., Lee K. Mitochondria and redox homoeostasis as chemotherapeutic targets. Biochem Soc Trans. 2014 Aug; 42(4): 939–44. doi: 10.1042/BST20140087.</mixed-citation><mixed-citation xml:lang="en">Briehl M.M., Tome M.E., Wilkinson S.T., Jaramillo M.C., Lee K. Mitochondria and redox homoeostasis as chemotherapeutic targets. Biochem Soc Trans. 2014 Aug; 42(4): 939–44. doi: 10.1042/BST20140087.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Munro D., Treberg J.R. A radical shift in perspective: mitochondria as regulators of reactive oxygen species. J Exp Biol. 2017; 220(Pt 7): 1170–80. doi: 10.1242/jeb.132142.</mixed-citation><mixed-citation xml:lang="en">Munro D., Treberg J.R. A radical shift in perspective: mitochondria as regulators of reactive oxygen species. J Exp Biol. 2017; 220(Pt 7): 1170–80. doi: 10.1242/jeb.132142.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Xia Y., Lu Z. Metabolic features of cancer cells. Cancer Commun. (Lond). 2018 Oct 30; 38(1): 65. doi: 10.1186/s40880-018-0335-7.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Xia Y., Lu Z. Metabolic features of cancer cells. Cancer Commun. (Lond). 2018 Oct 30; 38(1): 65. doi: 10.1186/s40880-018-0335-7.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao M., Zhong H., Xia L., Tao Y., Yin H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Biol Med. 2017 Oct; 111: 316–327. doi: 10.1016/j.freeradbiomed.2017.04.363.</mixed-citation><mixed-citation xml:lang="en">Xiao M., Zhong H., Xia L., Tao Y., Yin H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Biol Med. 2017 Oct; 111: 316–327. doi: 10.1016/j.freeradbiomed.2017.04.363.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Z., Chang H., Li H., Wang S. Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis. 2017 Nov; 22(11): 1321–1335. doi: 10.1007/s10495-017-1424-9.</mixed-citation><mixed-citation xml:lang="en">Zou Z., Chang H., Li H., Wang S. Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis. 2017 Nov; 22(11): 1321–1335. doi: 10.1007/s10495-017-1424-9.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов Д.С., Рязанцева Н.В., Степовая Е.А., Носарева О.Л., Шахристова Е.В., Иванов В.В. Редокс-зависимые механизмы дизрегуляции апоптоза опухолевых клеток при гипоксии. Сибирский научный медицинский журнал. 2017; 37(1): 21–26. doi: 10.21294/1814-4861-2016-15-6-42-47</mixed-citation><mixed-citation xml:lang="en">Orlov D.S., Ryazantseva N.V., Stepovaya E.A., Nosareva O.L., Shakhristova E.V., Ivanov V.V. Mechanisms of apoptosis dysregulation in cancer cells under the conditions of redox status modulation. Siberian Scientific Medical Journal. 2017; 37(1): 21–26. (in Russian). doi: 10.21294/1814-4861- 2016-15-6-42-47</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
